and pharmaceutically-acceptable salts and solvates thereof in which the
compound is present as solid particles not intimately embedded in a
polymeric co-precipitate, wherein at least 90% of the particles have a
particle size of less than about 40 microns; and
(b) one or more pharmaceutically-acceptable carriers, diluents, or
excipients"

Anspruch 5 unterscheidet sich von Anspruch 1 dadurch, dass er sich auf
eine pharmazeutische Formulierung bezieht, welche neben der in
Anspruch 1 beanspruchten Verbindung "(b) one or more
pharmaceutically-acceptable carriers, diluents, or excipients" enthält.